264 related articles for article (PubMed ID: 30710016)
1. Interactions of fatty acids, nonsteroidal anti-inflammatory drugs, and coxibs with the catalytic and allosteric subunits of cyclooxygenases-1 and -2.
Smith WL; Malkowski MG
J Biol Chem; 2019 Feb; 294(5):1697-1705. PubMed ID: 30710016
[TBL] [Abstract][Full Text] [Related]
2. Fatty Acid Binding to the Allosteric Subunit of Cyclooxygenase-2 Relieves a Tonic Inhibition of the Catalytic Subunit.
Dong L; Yuan C; Orlando BJ; Malkowski MG; Smith WL
J Biol Chem; 2016 Dec; 291(49):25641-25655. PubMed ID: 27756840
[TBL] [Abstract][Full Text] [Related]
3. Different Fatty Acids Compete with Arachidonic Acid for Binding to the Allosteric or Catalytic Subunits of Cyclooxygenases to Regulate Prostanoid Synthesis.
Dong L; Zou H; Yuan C; Hong YH; Kuklev DV; Smith WL
J Biol Chem; 2016 Feb; 291(8):4069-78. PubMed ID: 26703471
[TBL] [Abstract][Full Text] [Related]
4. Pre-existent asymmetry in the human cyclooxygenase-2 sequence homodimer.
Dong L; Sharma NP; Jurban BJ; Smith WL
J Biol Chem; 2013 Oct; 288(40):28641-55. PubMed ID: 23955344
[TBL] [Abstract][Full Text] [Related]
5. Cyclooxygenase Allosterism, Fatty Acid-mediated Cross-talk between Monomers of Cyclooxygenase Homodimers.
Yuan C; Sidhu RS; Kuklev DV; Kado Y; Wada M; Song I; Smith WL
J Biol Chem; 2009 Apr; 284(15):10046-55. PubMed ID: 19218248
[TBL] [Abstract][Full Text] [Related]
6. Interactions of 2-O-arachidonylglycerol ether and ibuprofen with the allosteric and catalytic subunits of human COX-2.
Dong L; Zou H; Yuan C; Hong YH; Uhlson CL; Murphy RC; Smith WL
J Lipid Res; 2016 Jun; 57(6):1043-50. PubMed ID: 27059979
[TBL] [Abstract][Full Text] [Related]
7. Human cyclooxygenase-2 is a sequence homodimer that functions as a conformational heterodimer.
Dong L; Vecchio AJ; Sharma NP; Jurban BJ; Malkowski MG; Smith WL
J Biol Chem; 2011 May; 286(21):19035-46. PubMed ID: 21467029
[TBL] [Abstract][Full Text] [Related]
8. A seven-step plan for becoming a moderately rich and famous biochemist.
Smith WL
J Biol Chem; 2019 Feb; 294(6):1779-1793. PubMed ID: 30737317
[TBL] [Abstract][Full Text] [Related]
9. Comparison of cyclooxygenase-1 crystal structures: cross-talk between monomers comprising cyclooxygenase-1 homodimers.
Sidhu RS; Lee JY; Yuan C; Smith WL
Biochemistry; 2010 Aug; 49(33):7069-79. PubMed ID: 20669977
[TBL] [Abstract][Full Text] [Related]
10. An attempt to chemically state the cross-talk between monomers of COX homodimers by double/hybrid inhibitors mofezolac-spacer-mofezolac and mofezolac-spacer-arachidonic acid.
Perrone MG; Miciaccia M; Vitale P; Ferorelli S; Araújo CDCB; de Almeida GS; Souza Domingos TF; da Silva LCRP; de Pádula M; Cabral LM; Sathler PC; Bonaccorso C; Fortuna CG; Scilimati A
Eur J Med Chem; 2021 Jan; 209():112919. PubMed ID: 33129592
[TBL] [Abstract][Full Text] [Related]
11. Coxibs interfere with the action of aspirin by binding tightly to one monomer of cyclooxygenase-1.
Rimon G; Sidhu RS; Lauver DA; Lee JY; Sharma NP; Yuan C; Frieler RA; Trievel RC; Lucchesi BR; Smith WL
Proc Natl Acad Sci U S A; 2010 Jan; 107(1):28-33. PubMed ID: 19955429
[TBL] [Abstract][Full Text] [Related]
12. Cyclooxygenase-2: a therapeutic target.
Turini ME; DuBois RN
Annu Rev Med; 2002; 53():35-57. PubMed ID: 11818462
[TBL] [Abstract][Full Text] [Related]
13. Human cyclooxygenase-1 activity and its responses to COX inhibitors are allosterically regulated by nonsubstrate fatty acids.
Zou H; Yuan C; Dong L; Sidhu RS; Hong YH; Kuklev DV; Smith WL
J Lipid Res; 2012 Jul; 53(7):1336-47. PubMed ID: 22547204
[TBL] [Abstract][Full Text] [Related]
14. The structure of mammalian cyclooxygenases.
Garavito RM; Mulichak AM
Annu Rev Biophys Biomol Struct; 2003; 32():183-206. PubMed ID: 12574066
[TBL] [Abstract][Full Text] [Related]
15. Anti-inflammatory drugs in the 21st century.
Rainsford KD
Subcell Biochem; 2007; 42():3-27. PubMed ID: 17612044
[TBL] [Abstract][Full Text] [Related]
16. The cyclooxygenase isoforms: structural insights into the conversion of arachidonic acid to prostaglandins.
Garavito RM; DeWitt DL
Biochim Biophys Acta; 1999 Nov; 1441(2-3):278-87. PubMed ID: 10570255
[TBL] [Abstract][Full Text] [Related]
17. Two-pronged approach to anti-inflammatory therapy through the modulation of the arachidonic acid cascade.
Sala A; Proschak E; Steinhilber D; Rovati GE
Biochem Pharmacol; 2018 Dec; 158():161-173. PubMed ID: 30315753
[TBL] [Abstract][Full Text] [Related]
18. The future of traditional nonsteroidal antiinflammatory drugs and cyclooxygenase-2 inhibitors in the treatment of inflammation and pain.
Sciulli MG; Capone ML; Tacconelli S; Patrignani P
Pharmacol Rep; 2005; 57 Suppl():66-85. PubMed ID: 16415488
[TBL] [Abstract][Full Text] [Related]
19. A cyclooxygenase-2-dependent prostaglandin E2 biosynthetic system in the Golgi apparatus.
Yuan C; Smith WL
J Biol Chem; 2015 Feb; 290(9):5606-20. PubMed ID: 25548276
[TBL] [Abstract][Full Text] [Related]
20. Dual acting anti-inflammatory drugs: a reappraisal.
Bertolini A; Ottani A; Sandrini M
Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
